Infection from transplanted tissue is extremely rare. The Food and Drug Administration (FDA) has closely regulated this field since 1993 and made continual improvements to all stages of the process. Studies show that the risk of transmitting human immunodeficiency virus (HIV) through allograft is less than 1 in 1.67 million.
